Literature DB >> 3416119

Clinicopathological assessment and staging of colorectal cancer.

N S Williams1, J R Jass, J D Hardcastle.   

Abstract

Compared with various common neoplasms, there is no national or international agreed clinicopathological staging system for colorectal cancer. Before such a system can be developed, however, there has to be agreement on the methods used for assessment. The Colorectal Subcommittee of the United Kingdom Co-ordinating Committee on Cancer Research has, through its working party on staging, agreed various recommendations as to how the clinical and pathological assessment of patients with colorectal cancer can be standardized. By applying these standardized criteria, patients undergoing surgery can be divided into those having curative or non-curative operations, or operations which are indeterminate for cure. These recommendations represent the first step in ensuring uniformity in the classification of patients with colorectal cancer.

Entities:  

Mesh:

Year:  1988        PMID: 3416119     DOI: 10.1002/bjs.1800750710

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

Review 1.  Pre-operative evaluation of patients with low rectal carcinoma.

Authors:  P Durdey; N S Williams
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

2.  Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia.

Authors:  N Scott; I Martin; A S Jack; M F Dixon; P Quirke
Journal:  Clin Mol Pathol       Date:  1996-06

3.  Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma.

Authors:  A I Sarela; R C Macadam; S M Farmery; A F Markham; P J Guillou
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

Review 4.  Pathologic prognostic factors for gastrointestinal cancer.

Authors:  T Ismail; M T Hallissey; J W Fielding
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

5.  Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy.

Authors:  Antonio I Picon; Harvey G Moore; Stephen S Sternberg; Bruce D Minsky; Philip B Paty; David Blumberg; Stuart H Quan; W Douglas Wong; Alfred M Cohen; Jose G Guillem
Journal:  Int J Colorectal Dis       Date:  2003-06-03       Impact factor: 2.571

6.  Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer.

Authors:  K F Chin; J Greenman; E Gardiner; H Kumar; K Topping; J Monson
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

7.  Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer.

Authors:  M A Chapman; D Buckley; D B Henson; N C Armitage
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.